Jammu, India

Abid Hamid

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abid Hamid. Retrieved from https://idiyas.com/inventor/abid-hamid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abid Hamid: Innovator in Anticancer Research

Introduction

Abid Hamid is a notable inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His work focuses on innovative compounds that have the potential to combat cancer effectively.

Latest Patents

Abid Hamid holds a patent for "10-substituted colchicinoids as potent anticancer agents." This invention relates to specific compounds that exhibit antiproliferative activity, which can be utilized in the prevention and treatment of cancer. The compounds of formula I, as described in his patent, represent a promising avenue for cancer therapy.

Career Highlights

Abid Hamid is affiliated with the Council of Scientific & Industrial Research, where he engages in groundbreaking research. His dedication to advancing cancer treatment through innovative compounds has positioned him as a key figure in his field.

Collaborations

Some of his notable coworkers include Ram Asrey Vishwakarma and Sandip Bibishan Bharate. Their collaborative efforts contribute to the ongoing research and development of effective cancer therapies.

Conclusion

Abid Hamid's work in developing anticancer agents showcases his commitment to improving healthcare through innovation. His contributions are vital in the fight against cancer, and his patent reflects the potential for significant advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…